GYRE
Price
$7.71
Change
-$0.03 (-0.39%)
Updated
Sep 2 closing price
Capitalization
700.27M
70 days until earnings call
SPRC
Price
$2.44
Change
-$0.02 (-0.81%)
Updated
Sep 2 closing price
Capitalization
1.3M
Interact to see
Advertisement

GYRE vs SPRC

Header iconGYRE vs SPRC Comparison
Open Charts GYRE vs SPRCBanner chart's image
Gyre Therapeutics
Price$7.71
Change-$0.03 (-0.39%)
Volume$82.21K
Capitalization700.27M
SciSparc
Price$2.44
Change-$0.02 (-0.81%)
Volume$298.29K
Capitalization1.3M
GYRE vs SPRC Comparison Chart in %
Loading...
GYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GYRE vs. SPRC commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GYRE is a StrongBuy and SPRC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (GYRE: $7.74 vs. SPRC: $2.46)
Brand notoriety: GYRE and SPRC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GYRE: 64% vs. SPRC: 147%
Market capitalization -- GYRE: $700.27M vs. SPRC: $1.3M
GYRE [@Biotechnology] is valued at $700.27M. SPRC’s [@Biotechnology] market capitalization is $1.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GYRE’s FA Score shows that 1 FA rating(s) are green whileSPRC’s FA Score has 1 green FA rating(s).

  • GYRE’s FA Score: 1 green, 4 red.
  • SPRC’s FA Score: 1 green, 4 red.
According to our system of comparison, GYRE is a better buy in the long-term than SPRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GYRE’s TA Score shows that 5 TA indicator(s) are bullish while SPRC’s TA Score has 4 bullish TA indicator(s).

  • GYRE’s TA Score: 5 bullish, 4 bearish.
  • SPRC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GYRE is a better buy in the short-term than SPRC.

Price Growth

GYRE (@Biotechnology) experienced а -5.38% price change this week, while SPRC (@Biotechnology) price change was -46.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

GYRE is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GYRE($700M) has a higher market cap than SPRC($1.3M). GYRE has higher P/E ratio than SPRC: GYRE (385.50) vs SPRC (0.00). GYRE YTD gains are higher at: -36.033 vs. SPRC (-67.725). GYRE has more cash in the bank: 54.4M vs. SPRC (1.54M). SPRC has less debt than GYRE: SPRC (46K) vs GYRE (1.39M).
GYRESPRCGYRE / SPRC
Capitalization700M1.3M53,681%
EBITDA11.5MN/A-
Gain YTD-36.033-67.72553%
P/E Ratio385.500.0019,381,599%
Revenue102MN/A-
Total Cash54.4M1.54M3,532%
Total Debt1.39M46K3,028%
FUNDAMENTALS RATINGS
GYRE: Fundamental Ratings
GYRE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GYRESPRC
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 6 days ago
88%
Momentum
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GORO0.510.04
+8.18%
Gold Resource Corp
USBC1.060.04
+3.92%
USBC Inc
SFD25.510.08
+0.31%
Smithfield Foods Inc
NTB44.41-0.71
-1.57%
Bank of NT Butterfield & Son Limited (The)
SVIIU11.81-1.08
-8.38%
Spring Valley Acquisition Corp

GYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GYRE has been closely correlated with SPHDF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if GYRE jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GYRE
1D Price
Change %
GYRE100%
-6.52%
SPHDF - GYRE
82%
Closely correlated
N/A
SPRC - GYRE
38%
Loosely correlated
-18.81%
BEAM - GYRE
38%
Loosely correlated
-2.91%
RCKT - GYRE
35%
Loosely correlated
-2.09%
AURA - GYRE
35%
Loosely correlated
-2.64%
More

SPRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRC has been loosely correlated with ABCZF. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRC jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRC
1D Price
Change %
SPRC100%
-0.81%
ABCZF - SPRC
48%
Loosely correlated
N/A
ASMB - SPRC
45%
Loosely correlated
-2.31%
OPORF - SPRC
42%
Loosely correlated
N/A
GYRE - SPRC
38%
Loosely correlated
-0.39%
SPHDF - SPRC
34%
Loosely correlated
N/A
More